Area of research
Psychiatry and Mental health · Geriatrics and Gerontology
Research interest
Research interests include Schizophrenia research and treatment, Dementia and Cognitive Impairment Research, Bipolar Disorder and Treatment, and Pharmaceutical Practices and Patient Outcomes.
Real-world effectiveness of pharmacological maintenance treatment of bipolar depression: a within-subject analysis in a Swedish nationwide cohort
Pneumonia Risk, Antipsychotic Dosing, and Anticholinergic Burden in Schizophrenia
Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case–control study in Finland
Antipsychotic Use and Risk of Breast Cancer in Women With Severe Mental Illness: Replication of a Nationwide Nested Case–Control Database Study
Comparative Effectiveness of Antipsychotics in Patients With Schizophrenia Spectrum Disorder
The impact of rare protein coding genetic variation on adult cognitive function
Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study
Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends
Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials
Primary Nonadherence to Antipsychotic Treatment Among Persons with Schizophrenia
Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse
Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients
Mortality in psychotic depression: 18-year follow-up study
Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts
Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia
Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder – A nationwide cohort study
Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland
Long-term Continuity of Antipsychotic Treatment for Schizophrenia: A Nationwide Study
Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study
Morbidity and mortality in schizophrenia with comorbid substance use disorders
20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)
The clinical course of schizophrenia in women and men—a nation-wide cohort study
Employment among people with schizophrenia or bipolar disorder: A population‐based study using nationwide registers
Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia
In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine
Antipsychotic use among persons with schizophrenia in Sweden and Finland, trends and differences
Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia
Metformin and Risk of Alzheimer’s Disease Among Community-Dwelling People With Diabetes: A National Case-Control Study
Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder
Mortality in schizophrenia: 30‐year nationwide follow‐up study